= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) CUSTOMARILY AND ACTUALLY TREATED BY THE REGISTRANT AS PRIVATE OR CONFIDENTIAL.Valneva SE • March 30th, 2023 • Biological products, (no disgnostic substances)
DISTRIBUTION AGREEMENT [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) CUSTOMARILY AND ACTUALLY TREATED BY THE REGISTRANT AS PRIVATE OR CONFIDENTIAL.Distribution Agreement • March 30th, 2023 • Valneva SE • Biological products, (no disgnostic substances)
VBI Vaccines B.V., organized under the laws of the Netherlands, with its registered office at Queen’s Tower #714, Delflandlaan 1, 1062EA Amsterdam, the Netherlands, hereinafter referred to as “SUPPLIER”,
= CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) CUSTOMARILY AND ACTUALLY TREATED BY THE REGISTRANT AS PRIVATE OR CONFIDENTIAL. Amendment No. 4 to Research...Name of Agreement • March 30th, 2023 • Valneva SE • Biological products, (no disgnostic substances)
Name of Agreement: Research Collaboration and License Agreement (“Original Agreement”), as amended by Amendment No. 1 to Agreement dated as of July 14 2021 Amendment No. 2 to Agreement dated as of 10 November 2021 and Amendment No. 3 dated as of June 19, 2022 (the “Agreement”)
